Literature DB >> 17403431

Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism.

You-Hong Cheng1, Ayse Imir, Veysel Fenkci, Mehmet Bertan Yilmaz, Serdar E Bulun.   

Abstract

OBJECTIVE: In endometrium, stromal progesterone receptors mediate production of paracrine factors, which enhance binding of the transcription factor specific protein-1 to the promoter of the gene encoding the 17beta-hydroxysteroid dehydrogenase type 2 enzyme responsible for converting biologically active estradiol to estrone in epithelium. The objective of this study is to define the cellular defect responsible for the disruption of this stromal-epithelial interaction in endometriosis. STUDY
DESIGN: We determined the effects of conditioned media generated from primary human eutopic endometrial stromal cells vs endometriotic stromal cells on Ishikawa malignant endometrial epithelial cells.
RESULTS: Conditioned media from progestin-pretreated eutopic endometrial stromal cells but not endometriotic stromal cells significantly stimulated specific protein-1 protein levels, 17beta-hydroxysteroid dehydrogenase type 2 messenger RNA levels and promoter activity, and binding activity of specific protein-1 to the 17beta-hydroxysteroid dehydrogenase type 2 promoter region in Ishikawa cells.
CONCLUSION: A stromal cell defect in endometriosis blocks formation of progesterone-dependent production of factors leading to 17beta-hydroxysteroid dehydrogenase type 2 deficiency and defective conversion of estradiol to estrone in epithelium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403431     DOI: 10.1016/j.ajog.2006.12.014

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  19 in total

1.  Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action.

Authors:  Mary Ellen Pavone; Matthew Dyson; Scott Reirstad; Elizabeth Pearson; Hiroshi Ishikawa; You Hong Cheng; Serdar E Bulun
Journal:  Hum Reprod       Date:  2011-06-08       Impact factor: 6.918

Review 2.  Aromatase inhibitors for the treatment of endometriosis.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  Fertil Steril       Date:  2012-09-19       Impact factor: 7.329

3.  Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics

Authors:  Maria M Szwarc; Lan Hai; William E Gibbons; Lisa D White; Qianxing Mo; Ramakrishna Kommagani; Rainer B Lanz; Francesco J DeMayo; Bert W O'Malley; John P Lydon
Journal:  Reproduction       Date:  2018-10-16       Impact factor: 3.906

4.  Altered retinoid uptake and action contributes to cell survival in endometriosis.

Authors:  Mary Ellen Pavone; Scott Reierstad; Hui Sun; Magdy Milad; Serdar E Bulun; You-Hong Cheng
Journal:  J Clin Endocrinol Metab       Date:  2010-08-11       Impact factor: 5.958

Review 5.  Endometriosis.

Authors:  Serdar E Bulun; Bahar D Yilmaz; Christia Sison; Kaoru Miyazaki; Lia Bernardi; Shimeng Liu; Amanda Kohlmeier; Ping Yin; Magdy Milad; JianJun Wei
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

Review 6.  The non-human primate model of endometriosis: research and implications for fecundity.

Authors:  A G Braundmeier; A T Fazleabas
Journal:  Mol Hum Reprod       Date:  2009-07-24       Impact factor: 4.025

7.  Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.

Authors:  Jennifer L Eaton; Kenji Unno; Marshall Caraveo; Zhenxiao Lu; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2013-09-24       Impact factor: 5.958

Review 8.  Pathophysiology and Immune Dysfunction in Endometriosis.

Authors:  Soo Hyun Ahn; Stephany P Monsanto; Caragh Miller; Sukhbir S Singh; Richard Thomas; Chandrakant Tayade
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

Review 9.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

Review 10.  17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis.

Authors:  Serdar E Bulun; You-Hong Cheng; Mary Ellen Pavone; Ping Yin; Gonca Imir; Hiroki Utsunomiya; Stephen Thung; Qing Xue; Erica E Marsh; Hideki Tokunaga; Hiroshi Ishikawa; Takeshi Kurita; Emily J Su
Journal:  Semin Reprod Med       Date:  2010-01       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.